A detailed history of Holocene Advisors, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Holocene Advisors, LP holds 2,529,024 shares of AZN stock, worth $197 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
2,529,024
Previous 5,473,372 53.79%
Holding current value
$197 Million
Previous $371 Million 46.81%
% of portfolio
0.87%
Previous 1.41%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $197 Million - $238 Million
-2,944,348 Reduced 53.79%
2,529,024 $197 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $79.1 Million - $90.1 Million
1,295,279 Added 31.0%
5,473,372 $371 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $105 Million - $118 Million
1,702,482 Added 68.77%
4,178,093 $281 Million
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $50.2 Million - $55.5 Million
774,722 Added 45.55%
2,475,611 $168 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $741,535 - $804,116
-10,607 Reduced 0.62%
1,700,889 $122 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $43.5 Million - $49.3 Million
-689,168 Reduced 28.71%
1,711,496 $119 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $16.4 Million - $21.2 Million
301,632 Added 14.37%
2,400,664 $163 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $18.9 Million - $48.3 Million
356,026 Added 20.43%
2,099,032 $115 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $103 Million - $124 Million
1,743,006 New
1,743,006 $115 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $62.1 Million - $73.4 Million
-1,149,393 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $15.5 Million - $17 Million
279,399 Added 32.12%
1,149,393 $69 Million
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $14.5 Million - $18 Million
-299,187 Reduced 25.59%
869,994 $52.1 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $55.1 Million - $63.7 Million
1,169,181 New
1,169,181 $58.1 Million
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $16.8 Million - $19.3 Million
-316,251 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $13.6 Million - $17.5 Million
316,251 New
316,251 $16.7 Million
Q1 2020

May 15, 2020

SELL
$37.79 - $51.33 $6.25 Million - $8.48 Million
-165,275 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $46.1 Million - $54.7 Million
-1,084,967 Reduced 86.78%
165,275 $8.24 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $29.6 Million - $33.5 Million
736,876 Added 143.54%
1,250,242 $55.7 Million
Q2 2019

Aug 14, 2019

BUY
$37.28 - $41.68 $19.1 Million - $21.4 Million
513,366 New
513,366 $21.2 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $241B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.